Dominic Cundari
Vermogen: 16 772 $ op 31-05-2026
Vermogen: 16 772 $ op 31-05-2026
Dominic R.
Cundari is Chief Commercial Officer at DiaMedica Therapeutics, Inc. since 2022.
Formerly, Mr. Cundari was Senior Director-Vascular Franchise at Genentech, Inc. from 1988 to 2009.
Education includes undergraduate and graduate degrees from Villanova University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-06-2024 | 2.800 ( -.--% ) | 16 772 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Corporate Officer/Principal | 01-02-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01-01-2009 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
DiaMedica Therapeutics, Inc.
DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau